A case of successful treatment of nail psoriasis with abrocitinib
Teng Liu
Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorXiaoman Gao
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorWan Liu
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorCorresponding Author
Jianmin Chang
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Correspondence
Jianmin Chang, MD, Department of Dermatology, Beijing Hospital, No. 1 Dong Da Hua Road, Dongcheng District, Beijing 100730, China.
Email: [email protected]
Search for more papers by this authorTeng Liu
Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorXiaoman Gao
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorWan Liu
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Search for more papers by this authorCorresponding Author
Jianmin Chang
Department of Dermatology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
Correspondence
Jianmin Chang, MD, Department of Dermatology, Beijing Hospital, No. 1 Dong Da Hua Road, Dongcheng District, Beijing 100730, China.
Email: [email protected]
Search for more papers by this author
REFERENCES
- 1Iorizzo M, Tosti A. Updates in treatment and impact of nail psoriasis. Expert Rev Clin Immunol. 2023; 19(9): 1091-1100.
- 2Rigopoulos D, Baran R, Chiheb S, et al. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus. J Am Acad Dermatol. 2019; 81(1): 228-240.
- 3Ji C, Wang H, Bao C, et al. Challenge of Nail Psoriasis: An Update Review. Clin Rev Allergy Immunol. 2021; 61(3): 377-402.
- 4Hwang JK, Lipner SR. Treatment of Nail Psoriasis. Dermatol Clin. 2024; 42(3): 387-398.
- 5Husein-ElAhmed H, Husein-ElAhmed S. Bayesian network meta-analysis of head-to-head trials for complete resolution of nail psoriasis. Clin Exp Dermatol. 2023; 48(8): 895-902.
- 6Saulite I, Pilmane M, Guenova E, et al. Expression of inflammatory cytokines in psoriatic nails. J Eur Acad Dermatol Venereol. 2017; 31(4): e210-e212.
- 7Chen P, Liang J, Li C, et al. Abrocitinib as a Novel Treatment for Multiple Skin Disorders: 3 Case Reports and a Scoping Review. Clin Cosmet Investig Dermatol. 2024; 17: 35-40.
- 8Mitroi GG, Mitroi GF, Ică OM, et al. Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis. Life (Basel). 2024; 14(9): 1127.
- 9He J, Yang Y. Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review. J Dermatolog Treat. 2024; 35(1):2434094.
Online Version of Record before inclusion in an issue
